ArticleMolecules (Basel, Switzerland)2019
Phenolic Compounds from
Abstract read
In one paragraph
Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.
0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
36 citing papers in PubMed.
- 6-Prenylnaringenin-Its Beneficial Biological Effects and Possible Applications.International journal of molecular sciences · 2025Review
- Selective Antimicrobial and Cytotoxic Effects of Hop Compounds to Combat Poultry Antimicrobial Resistance.MicrobiologyOpen · 2025Article
- Review
- Antibacterial activity of tannin-free ethanolic extracts from medicinal plants against methicillin-resistant Staphylococcus aureus.BMC complementary medicine and therapies · 2025Article
- Hop (Molecules (Basel, Switzerland) · 2025Article
- Unraveling the molecular drivers of antibacterial prenylated (iso)flavonoids and chalcones against Streptococcus mutans.Scientific reports · 2025Article
- Hops bitter β-acids have antibacterial effects against sinonasal Staphylococcus aureus but also induce sinonasal cilia and mitochondrial dysfunction.International forum of allergy & rhinology · 2025Article
- Hop biomass waste against fire blight and black rot: an eco-friendly approach to crop protection.Frontiers in microbiology · 2025Article
- Antibacterial phenolic compounds from the flowering plants of Asia and the Pacific: coming to the light.Pharmaceutical biology · 2024Review
- Article
- Bio-enriched composite materials derived from waste cooking oil for selective reduction of odour intensity.Scientific reports · 2024Article
- Characteristics and Antimicrobial Activities of Iron Oxide Nanoparticles Obtained via Mixed-Mode Chemical/Biogenic Synthesis Using Spent Hop (Antibiotics (Basel, Switzerland) · 2024Article
- Evaluation of the Protoscolicidal Activity ofEvidence-based complementary and alternative medicine : eCAM · 2024Article
- Antimicrobial properties of WCO-based composites enriched with hops and curly sorrel for green building solutions.PloS one · 2024Article
- Antibacterial and Antimycotic Activity ofPharmaceuticals (Basel, Switzerland) · 2023Review
- Antifungal Activity of Hop Leaf Extracts and Xanthohumol on Two Strains ofMicroorganisms · 2023Article
- Phytochemistry and pharmacology of natural prenylated flavonoids.Archives of pharmacal research · 2023Review
- Deciphering anti-infectious compounds from Peruvian medicinalFrontiers in pharmacology · 2023Article
- Antibacterial potential of chalcones and its derivatives against3 Biotech · 2023Review
- Structure-dependent activity of plant natural products against methicillin-resistantFrontiers in microbiology · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Laetitia BocquetEA 7394-ICV, Charles Viollette Research Institute, SFR Condorcet FR CNRS 3417, Univ. Lille, INRA, ISA-Yncréa, Univ. Artois, University Littoral Côte d'Opale, 3 rue du Professeur Laguesse, 59000 Lille, France. laetitia.bocquet1309@gmail.com.
Sevser SahpazEA 7394-ICV, Charles Viollette Research Institute, SFR Condorcet FR CNRS 3417, Univ. Lille, INRA, ISA-Yncréa, Univ. Artois, University Littoral Côte d'Opale, 3 rue du Professeur Laguesse, 59000 Lille, France. sevser.sahpaz@univ-lille.fr.
Natacha BonneauEA 7394-ICV, Charles Viollette Research Institute, SFR Condorcet FR CNRS 3417, Univ. Lille, INRA, ISA-Yncréa, Univ. Artois, University Littoral Côte d'Opale, 3 rue du Professeur Laguesse, 59000 Lille, France. natacha.bonneau@univ-lille.fr.
Claire BeaufayPharmacognosy Research group, Louvain Drug Research Institute, Université Catholique de Louvain, 1200 Brussels, Belgium. claire.beaufay@uclouvain.be.
Séverine MahieuxU995-LIRIC, Lille Inflammation Research International Center, University Lille, Inserm, CHU Lille, 59000 Lille, France. severine.mahieux@univ-lille.fr.
Jennifer SamaillieEA 7394-ICV, Charles Viollette Research Institute, SFR Condorcet FR CNRS 3417, Univ. Lille, INRA, ISA-Yncréa, Univ. Artois, University Littoral Côte d'Opale, 3 rue du Professeur Laguesse, 59000 Lille, France. jennifer.samaillie@univ-lille.fr.
Vincent RoumyEA 7394-ICV, Charles Viollette Research Institute, SFR Condorcet FR CNRS 3417, Univ. Lille, INRA, ISA-Yncréa, Univ. Artois, University Littoral Côte d'Opale, 3 rue du Professeur Laguesse, 59000 Lille, France. vincent.roumy@univ-lille.fr.
Justine JacquinEA 7394-ICV, Charles Viollette Research Institute, SFR Condorcet FR CNRS 3417, Univ. Lille, INRA, ISA-Yncréa, Univ. Artois, University Littoral Côte d'Opale, 3 rue du Professeur Laguesse, 59000 Lille, France. justine.jacquin@yncrea.fr.
Simon BordageEA 7394-ICV, Charles Viollette Research Institute, SFR Condorcet FR CNRS 3417, Univ. Lille, INRA, ISA-Yncréa, Univ. Artois, University Littoral Côte d'Opale, 3 rue du Professeur Laguesse, 59000 Lille, France. simon.bordage@univ-lille.fr.
Thierry HennebelleEA 7394-ICV, Charles Viollette Research Institute, SFR Condorcet FR CNRS 3417, Univ. Lille, INRA, ISA-Yncréa, Univ. Artois, University Littoral Côte d'Opale, 3 rue du Professeur Laguesse, 59000 Lille, France. thierry.hennebelle@univ-lille.fr.
Feng ChaiU1008-Controlled Drug Delivery Systems and Biomaterials, University Lille, Inserm, CHU Lille, 59000 Lille, France. feng.chai@univ-lille.fr.
Joëlle Quetin-LeclercqPharmacognosy Research group, Louvain Drug Research Institute, Université Catholique de Louvain, 1200 Brussels, Belgium. joelle.leclercq@uclouvain.be.
Christel NeutU995-LIRIC, Lille Inflammation Research International Center, University Lille, Inserm, CHU Lille, 59000 Lille, France. christel.neut@univ-lille.fr.
Céline RivièreEA 7394-ICV, Charles Viollette Research Institute, SFR Condorcet FR CNRS 3417, Univ. Lille, INRA, ISA-Yncréa, Univ. Artois, University Littoral Côte d'Opale, 3 rue du Professeur Laguesse, 59000 Lille, France. celine.riviere@univ-lille.fr.
Funding
CPER/FEDER Alibiotech Project none
Abstract
New anti-infective agents are urgently needed to fight microbial resistance. Methicillin-resistant
Indexed as
Anti-Infective AgentsBacterial InfectionsBiofilmsBiological ProductsHumansHumulusLeishmania mexicanaMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsParasitic DiseasesTrypanosoma brucei bruceiAnti-Infective AgentsBiological Productsantimicrobial agentsHumulus lupulusLeishmania mexicana mexicanamethicillin-resistant Staphylococcus aureusprenylated phenolic compoundsTrypanosoma brucei brucei
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.